<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>atazanavir</title><link>http://www.unboundmedicine.com/medline/ebm/research/atazanavir</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918100/full_citation/P_glycoprotein_multidrug_resistance_associated_proteins_and_human_organic_anion_transporting_polypeptide_influence_the_intracellular_accumulation_of_atazanavir_</link><description>Janneh O, Anwar T, Jungbauer C, et al. <br/><span class="title">P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. [Journal Article]</span><br/><span class="source" title="Antiviral therapy">Antivir Ther 2009; 14(7):965-74.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918100/abstract/P_glycoprotein_multidrug_resistance_associated_proteins_and_human_organic_anion_transporting_polypeptide_influence_the_intracellular_accumulation_of_atazanavir_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918100/full_citation/P_glycoprotein_multidrug_resistance_associated_proteins_and_human_organic_anion_transporting_polypeptide_influence_the_intracellular_accumulation_of_atazanavir_">Full Citation</a></description></item><item><title>Gateways to clinical trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_</link><description>Tomillero A, Moral MA <br/><span class="title">Gateways to clinical trials. [Journal Article]</span><br/><span class="source" title="Methods and findings in experimental and clinical pharmacology">Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907722/abstract/Gateways_to_clinical_trials_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_">Full Citation</a></description></item><item><title>Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906626/full_citation/Electrocardiogram_abnormalities_with_atazanavir_and_lopinavir/ritonavir_</link><description>Rathbun CR, Liedtke MD, Blevins SM, et al. <br/><span class="title">Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir. [Journal Article]</span><br/><span class="source" title="HIV clinical trials">HIV Clin Trials 2009 Sep-Oct; 10(5):328-36.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906626/abstract/Electrocardiogram_abnormalities_with_atazanavir_and_lopinavir/ritonavir_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906626/full_citation/Electrocardiogram_abnormalities_with_atazanavir_and_lopinavir/ritonavir_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906626/Electrocardiogram_abnormalities_with_atazanavir_and_lopinavir/ritonavir_">Find Related Articles</a> </description></item><item><title>Factors influencing lopinavir and atazanavir plasma concentration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19897506/full_citation/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_</link><description>Stöhr W, Back D, Dunn D, et al. <br/><span class="title">Factors influencing lopinavir and atazanavir plasma concentration. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of antimicrobial chemotherapy">J Antimicrob Chemother 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19897506/abstract/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19897506/full_citation/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_">Full Citation</a></description></item><item><title>Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_</link><description>Quaranta S, Woloch C, Paccou A, et al. <br/><span class="title">Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/abstract/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19865000/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Find Related Articles</a> </description></item><item><title>Trends in uptake of recently approved antiretrovirals within a national healthcare system.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19863620/full_citation/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_</link><description>Belperio P, Mole L, Boothroyd D, et al. <br/><span class="title">Trends in uptake of recently approved antiretrovirals within a national healthcare system. [JOURNAL ARTICLE]</span><br/><span class="source" title="HIV medicine">HIV Med 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19863620/abstract/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19863620/full_citation/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19863620/Trends_in_uptake_of_recently_approved_antiretrovirals_within_a_national_healthcare_system_">Find Related Articles</a> </description></item><item><title>Clinical pharmacology, efficacy and safety of atazanavir: a review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19863454/full_citation/Clinical_pharmacology_efficacy_and_safety_of_atazanavir:_a_review_</link><description>Bentué-Ferrer D, Arvieux C, Tribut O, et al. <br/><span class="title">Clinical pharmacology, efficacy and safety of atazanavir: a review. [Journal Article]</span><br/><span class="source" title="Expert opinion on drug metabolism &amp; toxicology">Expert Opin Drug Metab Toxicol 2009 Nov; 5(11):1455-68.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19863454/abstract/Clinical_pharmacology_efficacy_and_safety_of_atazanavir:_a_review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19863454/full_citation/Clinical_pharmacology_efficacy_and_safety_of_atazanavir:_a_review_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19863454/Clinical_pharmacology_efficacy_and_safety_of_atazanavir:_a_review_">Find Related Articles</a> </description></item><item><title>Tenofovir Coadministration Is Not Associated With Lower Unboosted Atazanavir Plasma Exposure in the Clinical Setting.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19858926/full_citation/Tenofovir_Coadministration_Is_Not_Associated_With_Lower_Unboosted_Atazanavir_Plasma_Exposure_in_the_Clinical_Setting_</link><description>Calcagno A, Bonora S, Tettoni MC, et al. <br/><span class="title">Tenofovir Coadministration Is Not Associated With Lower Unboosted Atazanavir Plasma Exposure in the Clinical Setting. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Nov; 52(3):431-432.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19858926/full_citation/Tenofovir_Coadministration_Is_Not_Associated_With_Lower_Unboosted_Atazanavir_Plasma_Exposure_in_the_Clinical_Setting_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19858926/Tenofovir_Coadministration_Is_Not_Associated_With_Lower_Unboosted_Atazanavir_Plasma_Exposure_in_the_Clinical_Setting_">Find Related Articles</a> </description></item><item><title>Clinically Significant Adverse Events from a Drug Interaction Between Quetiapine and Atazanavir-Ritonavir in Two Patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19857154/full_citation/Clinically_Significant_Adverse_Events_from_a_Drug_Interaction_Between_Quetiapine_and_Atazanavir_Ritonavir_in_Two_Patients_</link><description>Pollack TM, McCoy C, Stead W <br/><span class="title">Clinically Significant Adverse Events from a Drug Interaction Between Quetiapine and Atazanavir-Ritonavir in Two Patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmacotherapy">Pharmacotherapy 2009 Nov; 29(11):1386-1391.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19857154/abstract/Clinically_Significant_Adverse_Events_from_a_Drug_Interaction_Between_Quetiapine_and_Atazanavir_Ritonavir_in_Two_Patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19857154/full_citation/Clinically_Significant_Adverse_Events_from_a_Drug_Interaction_Between_Quetiapine_and_Atazanavir_Ritonavir_in_Two_Patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19857154/Clinically_Significant_Adverse_Events_from_a_Drug_Interaction_Between_Quetiapine_and_Atazanavir_Ritonavir_in_Two_Patients_">Find Related Articles</a> </description></item><item><title>High Molecular Weight Form of Adiponectin in Antiretroviral Drug-induced Dyslipidemia in HIV-Infected Japanese Individuals Based on in vivo and in vitro Analyses.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19834271/full_citation/High_Molecular_Weight_Form_of_Adiponectin_in_Antiretroviral_Drug_induced_Dyslipidemia_in_HIV_Infected_Japanese_Individuals_Based_on_in_vivo_and_in_vitro_Analyses_</link><description>Minami R, Yamamoto M, Takahama S, et al. <br/><span class="title">High Molecular Weight Form of Adiponectin in Antiretroviral Drug-induced Dyslipidemia in HIV-Infected Japanese Individuals Based on in vivo and in vitro Analyses. [Journal Article]</span><br/><span class="source" title="Internal medicine (Tokyo, Japan)">Intern Med 2009; 48(20):1799-875.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19834271/abstract/High_Molecular_Weight_Form_of_Adiponectin_in_Antiretroviral_Drug_induced_Dyslipidemia_in_HIV_Infected_Japanese_Individuals_Based_on_in_vivo_and_in_vitro_Analyses_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19834271/full_citation/High_Molecular_Weight_Form_of_Adiponectin_in_Antiretroviral_Drug_induced_Dyslipidemia_in_HIV_Infected_Japanese_Individuals_Based_on_in_vivo_and_in_vitro_Analyses_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19834271/High_Molecular_Weight_Form_of_Adiponectin_in_Antiretroviral_Drug_induced_Dyslipidemia_in_HIV_Infected_Japanese_Individuals_Based_on_in_vivo_and_in_vitro_Analyses_">Find Related Articles</a> </description></item></channel></rss>